Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial

about

Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial

Item

http://www.wikidata.org/entity/Q58776138

description

scientific article published on 15 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Intravenous Infusion of Umbili ...... tis: A Phase Ia Clinical Trial

@en

Intravenous Infusion of Umbili ...... tis: A Phase Ia Clinical Trial

@nl

type

Item

label

Intravenous Infusion of Umbili ...... tis: A Phase Ia Clinical Trial

@en

Intravenous Infusion of Umbili ...... tis: A Phase Ia Clinical Trial

@nl

prefLabel

Intravenous Infusion of Umbili ...... tis: A Phase Ia Clinical Trial

@en

Intravenous Infusion of Umbili ...... tis: A Phase Ia Clinical Trial

@nl

P1476

Intravenous Infusion of Umbili ...... tis: A Phase Ia Clinical Trial

@en

P2093

Hee-Suk Lim

http://www.w3.org/2001/XMLSchema#string

Kwang-Won Seo

http://www.w3.org/2001/XMLSchema#string

Kyounghwan Roh

http://www.w3.org/2001/XMLSchema#string

Kyung-Sun Kang

http://www.w3.org/2001/XMLSchema#string

Seunghee Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis

Mesenchymal stem cells and immunomodulation: current status and future prospects

Multilineage potential of adult human mesenchymal stem cells

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

Multilineage cells from human adipose tissue: implications for cell-based therapies

Mesenchymal stem cells in health and disease

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis

P304

636-642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SCTM.18-0031

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eun Hye Park

KiChul Shin

P577

2018-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30112846

http://www.w3.org/2001/XMLSchema#string

P932

6127229

http://www.w3.org/2001/XMLSchema#string